全文获取类型
收费全文 | 84056篇 |
免费 | 6850篇 |
国内免费 | 1499篇 |
专业分类
耳鼻咽喉 | 629篇 |
儿科学 | 709篇 |
妇产科学 | 515篇 |
基础医学 | 3897篇 |
口腔科学 | 2321篇 |
临床医学 | 12566篇 |
内科学 | 7230篇 |
皮肤病学 | 401篇 |
神经病学 | 2220篇 |
特种医学 | 13671篇 |
外国民族医学 | 19篇 |
外科学 | 5633篇 |
综合类 | 16444篇 |
现状与发展 | 7篇 |
一般理论 | 39篇 |
预防医学 | 16919篇 |
眼科学 | 456篇 |
药学 | 3839篇 |
281篇 | |
中国医学 | 2215篇 |
肿瘤学 | 2394篇 |
出版年
2024年 | 58篇 |
2023年 | 1335篇 |
2022年 | 1998篇 |
2021年 | 3366篇 |
2020年 | 3571篇 |
2019年 | 2646篇 |
2018年 | 2583篇 |
2017年 | 2524篇 |
2016年 | 2708篇 |
2015年 | 2591篇 |
2014年 | 5928篇 |
2013年 | 5919篇 |
2012年 | 5733篇 |
2011年 | 6140篇 |
2010年 | 5334篇 |
2009年 | 4884篇 |
2008年 | 5045篇 |
2007年 | 4947篇 |
2006年 | 4381篇 |
2005年 | 3613篇 |
2004年 | 2920篇 |
2003年 | 2368篇 |
2002年 | 1884篇 |
2001年 | 1600篇 |
2000年 | 1241篇 |
1999年 | 960篇 |
1998年 | 765篇 |
1997年 | 685篇 |
1996年 | 550篇 |
1995年 | 545篇 |
1994年 | 425篇 |
1993年 | 286篇 |
1992年 | 223篇 |
1991年 | 281篇 |
1990年 | 257篇 |
1989年 | 234篇 |
1988年 | 233篇 |
1987年 | 195篇 |
1986年 | 186篇 |
1985年 | 185篇 |
1984年 | 208篇 |
1983年 | 139篇 |
1982年 | 161篇 |
1981年 | 111篇 |
1980年 | 123篇 |
1979年 | 54篇 |
1978年 | 68篇 |
1977年 | 72篇 |
1976年 | 62篇 |
1975年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
11.
《Journal of vascular and interventional radiology : JVIR》2022,33(6):660-667
PurposeTo investigate the safety and efficacy of an aqueous polyethylene glycol-based liquid embolic agent, Embrace Hydrogel Embolic System (HES), in the treatment of benign and malignant hypervascular tumors.Materials and MethodsA prospective, single-arm, multicenter study included 8 patients, 5 males and 3 females, with a median age of 58.5 years (30–85 years), who underwent embolization in 8 tumors between October 2019 and May 2020. Technical success was defined as successful delivery of HES to the index vessel, with disappearance of >90% of the targeted vascular enhancement or, for portal vein embolization, occlusion of the portal branches to the liver segments for future resection. The volume of HES administered, ease of use (5 point Likert scale), administration time, and adverse events (AEs) were recorded. Evaluation was performed at 7, 30, and 90 days via clinical assessment and blood testing, and follow-up imaging was performed at 30 days.ResultsEight patients were enrolled, and 10 embolizations were performed in 8 lesions. Tumors included hepatocellular carcinoma (n = 4), renal angiomyolipoma (n = 3), and intrahepatic cholangiocarcinoma (n = 1). Technical success was 100%, and the average ease of use was 3.3 ± 1.0 SD. The HES delivery time was 1–28 minutes (median, 16.5 minutes), and the HES volume injected was 0.4–4.0 mL (median, 1.3 mL). All patients reached 30-day follow-up with imaging, and 6 patients reached 90-day follow-up. There were 3 serious AEs in 2 patients that were unrelated to the embolic agent.ConclusionHES resulted in a 100% embolization technical success rate. The product ease of use was acceptable, and no target vessel recanalization was noted on follow-up imaging at 30 days. 相似文献
12.
13.
背景 人口老龄化趋势下,罹患多种慢性病的失能或半失能老年人对居家医疗护理服务需求迫切,但基层医务人员提供居家医疗护理服务存在较大的医疗风险和安全隐患,加强居家医疗护理服务的安全管理,有利于提高基层医务人员提供居家医疗护理服务的意愿。 目的 调查基层医疗卫生机构对居家护理服务的安全支持情况和医务人员的服务意愿,为进一步推动居家医疗护理服务发展提供参考依据。 方法 2021年8—10月,采用便利抽样法在四川省五大经济区抽取49所基层医疗卫生机构的1 131例医务人员。自行设计调查问卷,以"问卷星"电子问卷的形式收集资料。问卷内容包括医务人员的一般情况(8个条目)、提供居家医疗护理服务的经历(2个条目)、医疗机构对医务人员的安全支持(7个条目)、医务人员的居家医疗护理服务意愿(1个条目)。比较不同特征医务人员提供居家医疗护理服务的意愿,采用二元Logistic回归分析医务人员提供居家医疗护理服务意愿的影响因素。 结果 1 131例基层医务人员中,692例(61.18%)报告有过居家医疗护理服务的经历,193例(17.06%)报告在服务过程中发生过不良事件/安全事件,531例(46.95%)报告其所在医疗机构未评估过患者接受居家医疗护理服务的安全风险,199例(17.60%)表示所在机构评估了医务人员提供居家医疗护理服务的安全风险,299例(26.44%)在居家医疗护理服务过程中使用APP定位系统,273例(24.14%)由机构配备报警、延迟预警等设备,807例(71.35%)表示居家医疗护理服务过程中没有获得所在机构内其他医务人员的支持措施,303例(26.79%)表示机构曾组织居家医疗护理服务的专项研讨活动,352例(31.12%)表示接受过有关居家医疗护理服务专项培训,853例(75.42%)表示愿意提供居家医疗护理服务。二元Logistic回归分析结果显示,就职的基层医疗卫生机构类型,目前受聘的专业技术职称,医疗机构是否评估过患者接受居家医疗护理服务的安全风险,在居家医疗护理服务过程中是否配备报警、延迟预警等设备,是否参加过有关居家医疗护理服务的专项培训,对医务人员提供居家医疗护理服务意愿有影响(P<0.05)。 结论 现阶段居家医疗护理服务的安全支持不足,多种因素影响基层医务人员提供居家医疗护理服务的意愿。基层医疗卫生机构应加强对患者接受居家医疗护理服务安全风险的评估,为提供居家医疗护理服务的医务人员配备报警、延迟预警等设备,积极举办居家医疗护理服务相关的专项培训并鼓励医务人员参加,以降低医务人员提供居家医疗护理服务的风险,保障其人身安全。 相似文献
14.
15.
16.
The Postoperative Short Course Content Study group 《Anaesthesia》2022,77(5):570-579
Most surgical and anaesthetic mortality and morbidity occurs postoperatively, disproportionately affecting low- and middle-income countries. Various short courses have been developed to improve patient outcomes in low- and middle-income countries, but none specifically to address postoperative care and complications. We aimed to identify key features of a proposed short-course addressing this topic using a Delphi process with low- and middle-income country anaesthesia providers trained as short-course facilitators. An initial questionnaire was co-developed from literature review and exploratory workshops to include 108 potential course features. Features included content; teaching method; appropriate participants; and appropriate faculty. Over three Delphi rounds (panellists numbered 86, 64 and 35 in successive cycles), panellists indicated which features they considered most important. Responses were analysed by geographical regions: Africa, the Americas, south-east Asia and Western Pacific. Ultimately, panellists identified 60, 40 and 54 core features for the proposed course in each region, respectively. There were high levels of consensus within regions on what constituted core course content, but not between regions. All panellists preferred the small group workshop teaching method irrespective of region. All regions considered anaesthetists to be key facilitators, while all agreed that both anaesthetists and operating theatre nurses were key participants. The African and Americas regional panels recommended more multidisciplinary healthcare professionals for participant roles. Faculty from high-income countries were not considered high priority. Our study highlights variability between geographical regions as to which course features were perceived as most locally relevant, supporting regional adaptation of short-course design rather than a one-size-fits-all model. 相似文献
17.
《International journal of oral and maxillofacial surgery》2022,51(4):552-557
The aim of this retrospective study was to investigate the accuracy of dynamic navigation for the placement of intentionally tilted implants in the posterior maxilla. The study included 12 patients with edentulism or continuous multiple tooth loss, who had 48 implants inserted under dynamic navigation guidance in the posterior maxilla. Twenty-four implants near maxillary sinuses were intentionally tilted. The average platform deviation was 1.3 ± 0.4 mm (range 0.8–2.3 mm), apex deviation was 1.1 ± 0.5 mm (range 0.2–2.3 mm), and axis deviation was 3.1 ± 1.0° (range 1.8–6.7°). The other 24 implants were axially positioned. The average platform deviation was 1.5 ± 0.5 mm (range 0.7–3.1 mm), apex deviation was 1.3 ± 0.7 mm (range 0.5–3.1 mm), and axis deviation was 3.2 ± 1.5° (range 1.5–7.7°). There was no significant difference in platform deviation, apex deviation, or axis deviation between the tilted implants and implants in the axial position (P > 0.05). This analysis indicates that a dynamic navigation system can be used as a method of guidance to place intentionally tilted implants as accurately as axially positioned implants in the posterior maxilla, thereby preventing damage to the maxillary sinuses and the need to graft bone. 相似文献
18.
19.
20.
《Journal of vascular and interventional radiology : JVIR》2022,33(9):1045-1053
PurposeTo evaluate the efficacy and safety of microwave (MW) ablation as first-line locoregional therapy (LRT) for bridging patients with hepatocellular carcinoma (HCC) to liver transplant.Materials and MethodsThis retrospective study evaluated 88 patients who received percutaneous MW ablation for 141 tumors as first-line LRT for HCC and who were listed for liver transplantation at a single medical center between 2011 and 2019. The overall survival (OS) rate statuses after liver transplant, waitlist retention, and disease progression were evaluated using the Kaplan-Meier techniques.ResultsAmong the 88 patients (72 men and 16 women; mean age, 60 years; Model for End-Stage Liver Disease score, 11.2) who were listed for transplant, the median waitlist time was 9.4 months (interquartile range, 5.5–18.9). Seventy-one (80.7%) patients received transplant after a median waitlist time of 8.5 months. Seventeen (19.3%) patients were removed from the waitlist; of these, 4 (4.5%) were removed because of tumors outside of the Milan criteria (HCC-specific dropout). No difference in tumor size or alpha-fetoprotein was observed in the transplanted versus nontransplanted patients at the time of ablation (2.1 vs 2.1 cm and 34.4 vs 34.7 ng/mL for transplanted vs nontransplanted, respectively; P > .05). Five (5.1%) of the 88 patients experienced adverse events after ablation; however, they all recovered. There were no cases of tract seeding. The local tumor progression (LTP) rate was 7.2%. The OS status after liver transplant at 5 years was 76.7%, and the disease-specific survival after LTP was 89.6%, with a median follow-up of 61 months for all patients.ConclusionsMW ablation appears to be safe and effective for bridging patients with HCC to liver transplant without waitlist removal from seeding, adverse events, or LTP. 相似文献